{"id":"W2155039139","doi":"10.1016/s1474-4422(03)00502-7","title":"Treatment of Alzheimer's disease; current status and new perspectives","year":2003,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":725,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"American Academy of Neurology; Pfizer","keywords":"Rivastigmine; Memantine; Galantamine; Donepezil; Medicine; Disease; Tacrine; Dementia; Alzheimer's disease; Pharmacology; Acetylcholinesterase; Bioinformatics; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08731596543438518,"score_gpt":0.3504418202794293,"score_spread":0.2631258548450441,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}